Immune activation and normal levels of endogenous antivirals are seen in healthy adolescents born of HIV-infected mothers

AIDS

Volumn 21, Issue 2, 2007, Pages 245-248

  Vigano, Alessandra ^a   Saresella, Marina ^b   Schenal, Monica ^c   Erba, Paola ^a   Piacentini, Luca ^c   Tornaghi, Raffaella ^a   Naddeo, Valentina ^c   Giacomet, Vania ^a   Borelli, Manuela ^c   Trabattoni, Daria ^c   Clerici, Mario ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; MESSENGER RNA; TRIPARTITE MOTIF PROTEIN 5;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; DISEASE RESISTANCE; EXPOSURE; FETUS DEVELOPMENT; GENOME IMPRINTING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSTIMULATION; MOTHER; NORMAL HUMAN; PRIORITY JOURNAL; SCHOOL CHILD; SEXUAL TRANSMISSION; THYMUS; UTERUS; VERTICAL TRANSMISSION;

ADOLESCENT; ADULT; CHILD; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; IMMUNITY, CELLULAR; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 33845954397     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328011d7d3     Document Type: Article

References (18)

1. Mofenson LM. Mother-child HIV transmission: timing and determinants. Obstet Gynecol Clin North Am 1997; 24:759-784.
2. Kuhn L, Stein ZM. Mother-child HIV transmission: timing, risk factors and prevention. Paediatr Perinat Epidemiol 1995; 9:1-29.
3. Kind C, Rudin C, Siegrist C, Wyler CA, Biedermann K, Lauper U, et al. Prevention of vertical HIV infection: additive protective effect of elective cesarean section and zidovudine prophylaxis. AIDS 1998; 12:205-210.
4. Clerici M, Sison AV, Berzofsky JA, Rakusan TA, Brandt CD, Ellaurie M, et al. Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS 1993; 7:1427-1435.
5. Rowland-Jones SL, Nixon DF, Aldhous MC, Gotch F, Ariyoshi K, Hallam N, et al. HIV-specific cytotoxic T cell activity in an HIV exposed but uninfected infant. Lancet 1993; 341:860-861.
6. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000; 96:3866-3871.
7. Nielsen SD, Jeppesen DL, Kolte L, Clark DR, Soresen TU, Dreves AM, et al. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 2001; 98:398-404.
8. Bunders M, Thorne C, Newell ML. Maternal and infant factors and lymphocytre CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS 2005; 19:1071-1079.
9. Ono E, Santos AMN, Succi RCM, Machado DM, Kallas EG, Salomao R, et al. Lymphocyte subsets in HIV-1 exposed uninfected children at birth and at 1 year of age in the era of highly active antiretroviral therapy. In: 13th Conference on Retroviruses and Opportunistic Infections. Denver, CO, USA, 5-8 February 2006 [Poster 676].
10. Shah MM, Li Y, Christensen RD. Effects of perinatal zidovudine on hematopoiesis: a comparison of effects on progenitors from human fetuses versus mothers. AIDS 1996; 10:1239-1247.
11. Le Chenadec J, Mayaux MJ, Guihenneuc-Jouyaux C, Blanche S. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS 2003; 17:2053-2061.
12. Clerici M, Levin JM, Kessler HA, Harris A, Berzofsky JA, Landay AL, et al. HIV-specific T helper activity in HIV seronegative health care workers accidentally exposed to HIV-contaminated blood. JAMA 1994; 271:42-50.
13. Douglas SD, Rudy B, Muenz L, Starr SE, Campbell DE, Wilson C. Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents. AIDS 1999; 13:629-1635.
14. Levy JA. HIV and the pathogenesis of AIDS. 2nd ed. Washington, DC: American Society of Microbiology; 1998.
15. Appay V, Nixon DF, Donahoe SM, Gillespie GMA, Dong T, King A, et al. HIV-specific CD8R T cells produce antiviral cytokines but are impaired in cytolitic function. J Exp Med 2000; 192:63-70.
16. Bishop KN, Holmes RK, Sheehy AM, Davidson NO, Cho SJ, Malim MH. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr Biol 2004; 14:1392-1396.
17. Yap MW, Nisole S, Lynch C, Stoye JP. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A 2004; 101:10786-10791.
18. Biasin M, Piacentini L, Lo Caputo S, Kanari Y, Magri G, Trabattoni D, et al. APOBEC3G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals. J Inf Dis (in press).